| Announce Date | 12/03/2025 |
| EPS Normalized Actual | $0.41 (Beat by $0.52) |
| EPS GAAP Actual | $0.41 (Beat by $0.52) |
| Revenue Actual | $2.38912B |
| Revenue Surprise | Beat by $2389.12M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.61 |
| EPS GAAP Estimate | $1.61 |
| Revenue Estimate | $2.4548174B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jul 2028 | 9.97 | 12.02 | 9.43284 | 10.37139 | 1 |
| Jul 2028 | 6.87272 | 17.43 | 6.57445 | 7.13017 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.41 | -1.31 | 2.38912B | 10.31% | -317.01M |
| FQ3 2025 (Jul 2025) | 2.37 | 2.37 | 2.52378B | -0.41% | 2523.78M |
| FQ2 2025 (Apr 2025) | 2.54 | 2.54 | 2.89482B | 3.24% | 2894.82M |
| FQ1 2025 (Jan 2025) | -0.0581 | -0.0581 | 2.01811B | -9.38% | 2018.11M |
| FQ4 2024 (Oct 2024) | -0.0346 | -0.0346 | 2.14278B | -16.71% | 2142.78M |
| FQ3 2024 (Jul 2024) | 0 | 0 | 2.53417B | -8.05% | 2534.17M |
| FQ2 2024 (Apr 2024) | 2.15 | 2.15 | 2.80111B | 100% | 2801.11M |
| FQ1 2024 (Jan 2024) | 0.13 | 0.13 | 2.20737B | -6.31% | 2207.37M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
1.61
Consensus Revenue Estimates
2.4548174B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Apr 2028) | 3.24 | -- | 3.08798 | 3.40397 | 6 |
| FQ1 2028 (Jan 2028) | 0.53 | -- | 0.50513 | 0.55682 | 4 |
| FQ4 2027 (Oct 2027) | 1.15 | -- | 1.09604 | 1.2082 | 6 |
| FQ3 2027 (Jul 2027) | 2.9796 | -- | 2.75666 | 3.17684 | 11 |
| FQ2 2027 (Apr 2027) | 3.165 | -- | 2.92819 | 3.37451 | 10 |
| FQ1 2027 (Jan 2027) | 0.435 | -- | 0.39594 | 0.46236 | 9 |
| FQ4 2026 (Oct 2026) | 1.2834 | 68.05 | 1.18737 | 1.36836 | 9 |
| FQ3 2026 (Jul 2026) | 2.58 | 8.14 | 2.39905 | 2.79265 | 3 |
| FQ2 2026 (Apr 2026) | 3.09 | 17.8 | 2.87328 | 3.34468 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Apr 2028) | 3.05B | -- | 2.94B | 3.17B | 3 |
| FQ1 2028 (Jan 2028) | 2.13B | -- | 2.05B | 2.21B | 7 |
| FQ4 2027 (Oct 2027) | 2.68B | -- | 2.59B | 2.79B | 7 |
| FQ3 2027 (Jul 2027) | 2.95B | -- | 2.78B | 3.1B | 7 |
| FQ2 2027 (Apr 2027) | 3.12B | -- | 2.94B | 3.28B | 12 |
| FQ1 2027 (Jan 2027) | 2.17B | -- | 2.02B | 2.28B | 10 |
| FQ4 2026 (Oct 2026) | 2.53B | 5.42 | 2.38B | 2.65B | 7 |
| FQ3 2026 (Jul 2026) | 2.88B | 12.26 | 2.72B | 3.06B | 4 |
| FQ2 2026 (Apr 2026) | 3.21B | 9.7 | 3.03B | 3.41B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 1.72 | 0.41 | -1.31 | -319.51% |
| FQ3 2025 (Jul 2025) | 2.37 | 2.37 | 100% | |
| FQ2 2025 (Apr 2025) | 2.54 | 2.54 | 100% | |
| FQ1 2025 (Jan 2025) | -0.0581 | -0.0581 | 100% | |
| FQ4 2024 (Oct 2024) | -0.0346 | -0.0346 | 100% | |
| FQ3 2024 (Jul 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Apr 2024) | 2.15 | 2.15 | 100% | |
| FQ1 2024 (Jan 2024) | 0.13 | 0.13 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $2.71B | $2.39B | $-317.01M | -13.27% |
| FQ3 2025 (Jul 2025) | $0B | $2.52B | $2523.78M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $2.89B | $2894.82M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $2.02B | $2018.11M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $2.14B | $2142.78M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $2.53B | $2534.17M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $2.8B | $2801.11M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $2.21B | $2207.37M | 100% |